Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Tyrosyl-DNA phosphodiesterase 1 (TDP1) is critical for resolving stalled topoisomerase I–DNA complexes. Biallelic pathogenic variants in TDP1 cause spinocerebellar ataxia with axonal neuropathy type 1 (SCAN1; OMIM:607250), an ultrarare autosomal recessive neurodegenerative syndrome characterized by progressive cerebellar ataxia and peripheral axonal neuropathy.
The first causal link was established in a Saudi Arabian kindred by genome-wide linkage and positional cloning, identifying a homozygous NM_018319.4:c.1478A>G (p.His493Arg) variant disrupting a conserved active-site histidine and segregating with disease (PMID:12244316).
Independent replication in two unrelated Omani families (n = 4 affected) confirmed the same c.1478A>G (p.His493Arg) allele with shared haplotype and autosomal recessive transmission, substantiating a founder effect in the Middle East (PMID:31182267). More recently, whole-exome sequencing in a consanguineous Pakistani pedigree revealed a novel homozygous NM_018319.4:c.1432C>T (p.His478Tyr) variant, expanding both the genotypic and phenotypic spectra to include congenital onset SCAN1 (PMID:39576382).
Functional characterization shows that p.His493Arg reduces Tdp1 catalytic activity ~25-fold and traps a covalent Tdp1–DNA intermediate, leading to camptothecin hypersensitivity in patient cells and yeast rescue assays, consistent with a neomorphic loss-of-function mechanism (PMID:15920477). Mouse and cellular models replicate genome instability and neuronal vulnerability, aligning with human neurodegeneration.
Collectively, genetic segregation, recurrence of a founder variant, discovery of a novel allele, and concordant functional studies support a haploinsufficiency/neomorphic mechanism. Clinical features include cerebellar atrophy (HP:0001272), progressive cerebellar ataxia (HP:0002073), hypercholesterolemia (HP:0003124), elevated alpha-fetoprotein, and variable cognitive impairment.
Gene–Disease AssociationDefinitive≥5 probands across four unrelated families over >20 years; consistent autosomal recessive segregation and functional concordance ([PMID:12244316], [PMID:31182267], [PMID:39576382]) Genetic EvidenceStrongFive affected individuals from four independent families; autosomal recessive segregation confirmed; founder and novel allele replication cap reached Functional EvidenceModerateBiochemical assays show ~25-fold reduced Tdp1 activity and persistent Tdp1–DNA intermediate formation leading to camptothecin hypersensitivity in cells and yeast models ([PMID:15920477]) |